Antioxidants in patients with hyperthyroidism

Clinical Chemistry and Laboratory Medicine

Volumn 42, Issue 2, 2004, Pages 154-158

  Mayer, Ljiljana ^a   Romić, Željko ^a   Škreb, Franjo ^a   Bačić Vrca, Vesna ^a   Čepelak, Ivana ^b   Žanić Grubišić, Tihana ^b   Kirin, Marijan ^a  

^a University of Zagreb School of Medicine   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Glutathione peroxidase; Hyperthyroidism; Oxidative stress; Superoxide dismutase; Total antioxidant status

Indexed keywords

ANTIOXIDANT; ERYTHROCYTE ENZYME; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE; THIAMAZOLE; TRANSFERRIN; URIC ACID;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; URIC ACID BLOOD LEVEL;

ADULT; AGED; ANTIOXIDANTS; FEMALE; GLUTATHIONE REDUCTASE; HUMANS; HYPERTHYROIDISM; MIDDLE AGED; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 1642566541     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2004.028     Document Type: Article

References (32)

1. Wilson R, Chopra M, Bradley H, McKillop JH, Smith WE, Thomson JA. Free radicals and Graves' disease: The effects of therapy. Clin Endocrinol 1989;30:429-33.
2. Seven A, Seymen O, Hatemi S, Hatemi H, Yigit G, Candan G. Antioxidant status in experimental hyperthyroidism: Effect of vitamin E supplementation. Clin Chim Acta 1996;256:65-74.
3. Bianchi G, Solaroli E, Zaccheroni V, Grossi G, Bargossi AM, Melchionda N, et al. Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: Effect of treatment. Horm Metab Res 1999;31:620-4.
4. Asayama K, Dobashi K, Hayashibe H, Megata Y, Kato K. Lipid peroxidation and free radical scavengers in thyroid dysfunction in the rat: A possible mechanism of injury to heart and skeletal muscle in hyperthyroidism. Endocrinology 1987;121:2112-8.
5. Sadani GR, Nadkarni GD. Role of tissue antioxidant defence in thyroid cancers. Cancer Lett 1996;109:231-5.
6. Mano T, Shinohara R, Iwase K, Kotake M, Hamada M, Uchimuro K, et al. Changes in free radical scavengers and lipid peroxide in thyroid glands of various thyroid disorders. Horm Metab Res 1997;29:351-4.
7. Halliwell B, Gutteridge JM. Lipid peroxidation, oxygen radicals, cell damage and antioxidant therapy. Lancet 1984;1:1396-7.
8. Sies H, Stahl W, Sundquist AR. Antioxidant functions of vitamins. Vitamins E and C, beta-carotene, and other carotenoids. Ann NY Acad Sci 1992;669:7-20.
9. Morini P, Casalino E, Sblano C, Landriscina C. The response of rat liver peroxidation, antioxidant enzyme activities and glutathione concentration to the thyroid hormone. Int J Biochem 1991;23:1025-30.
10. Fernandez V, Videla LA. 3,3′,5-Triiodothyronine-induced hepatic respiration: Effects of desferrioxamine and allopurinol in the isolated perfused rat liver. Toxicol Lett 1993;69:205-10.
11. Das K, Chainy GB. Modulation of rat liver mitochondrial antioxidant defence system by thyroid hormone. Biochim Biophys Acta 2001;1537:1-13.
12. Rahaman SO, Ghosh S, Mohanakumar KP, Das S, Sarkar PK. Hypothyroidism in the developing rat brain is associated with marked oxidative stress and aberrant intraneuronal accumulation of neurofilaments. Neurosci Res 2001;40:273-9.
13. Resch U, Helsel G, Tatzber F, Sinzinger H. Antioxidant status in thyroid dysfunction. Clin Chem Lab Med 2002;40:1132-4.
14. Adali M, Inal-Erden M, Akalin A, Efe B. Effects of propylthiouracil, propranolol, and vitamin E on lipid peroxidation and antioxidant status in hyperthyroid patients. Clin Biochem 1999;32:363-7.
15. Komosinska-Vassev K, Olczyk K, Kucharz EJ, Marcisz C, Winsz-Szczotka K, Kotulska A. Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy. Clin Chim Acta 2000;300:107-17.
16. Guerra LN, Moiguer S, Karner M, de Molina MC, Sreider CM, Burdman JA. Antioxidants in the treatment of Graves disease. IUBMB Life 2001;51:105-9.
17. Ozdem S, Aliciguzel Y, Ozdem SS, Karayalcin U. Effects of propylthiouracil treatment on antioxidant activities in blood of toxic multinodular goiter patients. Pharmacology 2000;61:31-6.
18. Bolan BJ, Ulvik RJ. Improvement of a direct spectrophotometric assay for routine determination of superoxide dismutase activity. Clin Chem 1991;37:1993-9.
19. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-9.
20. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring antioxidant status in premature neonates. Clin Sci 1993;84:407-12.
21. Pereira B, Costa Rosa LF, Safi DA, Bechara EJ, Curi R. Control of superoxide dismutase, catalase and glutathione peroxidase activities in rat lymphoid organs by thyroid hormones. J Endocrinol 1994;140:73-7.
22. Sewerynek J, Wiktorska J, Nowak D, Lewinski A. Methimazole protection against oxidative stress induced by hyperthyroidism in Graves disease. Endocr Regul 2000;34:83-9.
23. Blum J, Fridovich I. Inactivation of glutathione peroxidase by superoxide radical. Arch Biochem Biophys 1985;240:500-8.
24. Köhrle J. Thyroid hormone deiodination in target tissues - a regulatory role for the trace element selenium? Exp Clin Endocrinol 1994;102:63-89.
25. Yu BP. Cellular defenses against damage from reactive oxygen species. Physiol Rev 1994;74:139-61.
26. Sato A, Shirota T, Shinoda T, Komiya I, Aizawa T, Takemura Y, et al. Hyperuricemia in patients with hyperthyroidism due to Graves' disease. Metabolism 1995;44:207-11.
27. Yazar A, Doven O, Atis S, Gen R, Pata C, Yazar EE, et al. Systolic pulmonary artery pressure and serum uric acid levels in patients with hyperthyroidism. Arch Med Res 2003;34:35-40.
28. Raber W, Vukovich T, Vierhapper H. Serum uric acid concentration and thyroid-stimulating hormone (TSH): Results of screening for hyperuricaemia in 2359 consecutive patients with various degrees of thyroid dysfunction. Wien Klin Wochenschr 1999;111:326-8.
29. Matsubara M, Koyanagawa Y, Odagaki E, Nakagawa K. Plasma transferrin levels in abnormal endocrine states. II. The changes in various endocrine states. Horm Metab Res 1989;21:334-7.
30. Graninger W, Pirich KR, Speiser W, Deutsch E, Waldhausl WK. Effect of thyroid hormones on plasma protein concentrations in man. J Clin Endocrinol Metab 1986;63:407-11.
31. Ghiselli A, Serafini M, Natella F, Scaccini C. Total antioxidant capacity as a tool to assess redox status: Critical view and experimental data. Free Rad Biol Med 2000;29:1106-14.
32. Janaszewska A, Bartosz G. Assay of total antioxidant capacity: Comparison of four methods as applied to human blood plasma. Scand J Clin Lab Invest 2002;62:231-6.